Real-time enrollment status for this proc clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 5:21 PM UTC
| NCT Number | NCT07470853 |
| Recruiting Status | Recruiting |
| Condition | PROC |
| Phase | PHASE1 |
| Target Enrollment | 265 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Whitehawk Therapeutics, Inc. |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 27, 2026: Clinical trial NCT07470853 is currently recruiting participants. This phase1 study for proc is actively seeking new participants at 12 locations across the United States. The study is sponsored by Whitehawk Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07470853 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07470853 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.